-Reuters
Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial
Athenex Inc (NASDAQ:ATNX) announced data presentation from a Phase 1 study evaluating encequidar (Oral Paclitaxel) in combination with Merck Co Inc’s (NYSE:MRK) Keytruda…